SELLAS Life Sciences Group, Inc. — Director's Dealing 2011

Sep 29, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (RXII)
CIK: 0001390478
Period of Report: 2011-09-27

Reporting Person: Nisi Rudolph (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-09-27	Stock Option (right to buy)	$0.85	A	100000	Acquired	2021-09-27	Common Stock (100000)	Direct

Footnotes

F1: Granted pursuant to the issuer's 2007 Incentive Plan

F2: Option vested and became exercisable immediately on the date of grant (i.e., September 27,2011)